✦ LIBER ✦

9228 POSTER Chemotherapy With Artificial Hyperglycemia in Treatment of Recurrent or Refractory Follicular Non-Hodgkin's Lymphomas

✍ Scribed by Pulatov, D.A.; Abdurahkmanov, D.A.; Djuraev, M.D.; Olimova, Z.A.

Book ID: 123085007
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)72493-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

48 Chemotherapy with short-term hypergly

48 Chemotherapy with short-term hyperglycemia in the treatment of refractory non-Hodgkin's lymphomas

✍ Z. Olimova; S. Navruzov; D. Pulatov; D. Abdurahkmanov; K. Tuydjanova 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase II Study of Efficacy and Safety of

Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non Small-Cell Lung Cancer

✍ Herbst, R. S.; O'Neill, V. J.; Fehrenbacher, L.; Belani, C. P.; Bonomi, P. D.; H 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 144 KB

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

6594 POSTER First-line bevacizumab in co

6594 POSTER First-line bevacizumab in combination with chemotherapy in the treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): an open-label safety study (MO19390)

✍ Crinó, L.; Dansin, E.; Garrido Lopez, P.; Griesinger, F.; Laskin, J.; Pavlakis, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB